Concepedia
Statistics
Publications
12
Citations
650
H-Index
Active since
2012
Affiliations
University of South Carolina(Current)
Duke University
The Ohio State University
Vanderbilt University Medical Center
University of Colorado Denver
Nirav Shah is an author at University of South Carolina specializing in molecular biology, life sciences, and molecular oncology.
Publications per year
2012–2023
Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling
Megan Moerdyk‐Schauwecker, Nirav Shah, Andrea M. Murphy et al. · Virology · 2012 · 126 citations
Life Sciences, Molecular Biology, Oncology +14
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19
Susanna Naggie, David R. Boulware, Christopher J. Lindsell et al. · JAMA · 2022 · 97 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +8
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19
Susanna Naggie, David R. Boulware, Christopher J. Lindsell et al. · JAMA · 2023 · 73 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +9
TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth
Nirav Shah, Sanjay Kumar, Naveed Zaman et al. · Nature Communications · 2018 · 63 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +15
A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth
Yogin Patel, Nirav Shah, Ji Shin Lee et al. · Oncotarget · 2016 · 61 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
1–5 of 12